Ultra-LEAF™ Purified anti-human CD28 Recombinant Antibody, CD28, S20013B.RecH4,BioLegend,377820
Clone S20013B.RecH4 antibody can completely block the binding of clone CD28.2 on target cells.Clone S20013B.RecH4 can partially block clone S20013F on target cells.Clone S20013B.RecH4 can increase anti-CD3-induced human peripheral T cell proliferation.Clone S20013B.RecH4 can induce proliferation of human peripheral T cells without anti-CD3 stimulation.
Host
Human
Reactivity
Human
Application
FC - Quality testedActiv - Verified
Platform ID
BAB885388127

BioLegend
Contact
Tel: 1-858-455-9588
Fax: +49 (4131) 7023913
Email:
Specifications
Scientific Background
CD28 is a 44 kD disulfide-linked homodimeric type I glycoprotein. It is a member of the immunoglobulin superfamily and is also known as T44 or Tp44. CD28 is expressed on most T lineage cells, NK cell subsets, and plasma cells. CD28 binds both CD80 and CD86 using a highly conserved motif MYPPY in the CDR3-like loop. CD28 is considered a major co-stimulatory molecule, inducing T lymphocyte activation and IL-2 synthesis, and preventing cell death.In vitrostudies indicate that ligation of CD28 on T cells by CD80 and CD86 on antigen presenting cells provides a costimulatory signal required for T cell activation and proliferation.
Category Paths
- Products>Primary Antibodies>Recombinant Antibodies
Please provide the required information below so that we can quickly source your products.
